Article
Prothrombin G20210A gene mutation, heparin cofactor II defects, primary (essential) thrombocythemia, and thrombohemorrhagic manifestations.
Seminars in thrombosis and hemostasis - 1 Jan 1999
Frenkel E P, Bick R L
Abstract excerpt
This article addresses the issue of thromboembolic disorders associated with the prothrombin G20210A gene mutation, with heparin cofactor II (HC-II) defects and with primary (essential) thrombocythemia. The prothrombin gene mutation is of recent discovery, is inherited as an autosomal dominant disorder, and seems to be highly prevalent in the general white population. The incidence is almost as high as that known...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
